Companies / Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc.
Insider flow · last 90 daysNet sells $70.3K
Financials · FY2017
Ownership
96.8M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 0.06% | 61,834 |
| 10%+ / strategic | 10.28% | 9,959,795 |
| Institutions | 84.46% | 81,790,007 |
| Public float | 5.19% | 5,028,796 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 6
View all →| Insider | % of shares | Shares |
|---|---|---|
Patou GaryDirector | 0.03% | 24,896 |
Mortimer IanCEOPRESIDENT & CEO · Director | 0.02% | 19,923 |
DiFabio AndreaChief Legal Officer | <0.01% | 7,301 |
Kenney Christopher JohnChief Medical Officer | <0.01% | 7,069 |
Machado PatrickDirector | <0.01% | 2,645 |
Cline Darren SChief Commercial Officer | — | — |
Institutional holders 263
View all →| Holder | Value | % of shares |
|---|---|---|
| $454.06M | 7.77% | |
| $399.81M | 9.21% | |
| $243.12M | 5.60% | |
| $242.86M | 4.31% | |
| $213.56M | 4.92% | |
| $203.42M | 4.69% | |
| $153.06M | 3.53% | |
| $118.89M | 2.03% | |
| $110.51M | 2.55% | |
| $93.95M | 1.67% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mortimer Ian CEO | Sell | Common Shares | $4.03M | -65K -91.55% | 6,000 <0.01% of shares | medium |
| Mar 9, 2026 | Mortimer Ian CEO | Sell | Common Shares | $3.70M | -62K -91.13% | 6,000 <0.01% of shares | medium |
| Mar 9, 2026 | Mortimer Ian CEO | Sell | Common Shares | $2.57M | -43K -37.37% | 72,652 0.08% of shares | medium |
| Mar 9, 2026 | Mortimer Ian CEO | Sell | Common Shares | $1.90M | -32K -53.53% | 27,515 0.03% of shares | medium |
| Jan 2, 2026 | Mortimer Ian CEO | Sell | Common Shares | $1.68M | -38K -82.47% | 8,062 <0.01% of shares | medium |
| Mar 9, 2026 | Mortimer Ian CEO | Sell | Common Shares | $1.30M | -22K -78.19% | 6,000 <0.01% of shares | medium |
| Mar 9, 2026 | Mortimer Ian CEO | Sell | Common Shares | $1.28M | -22K -26.90% | 59,209 0.06% of shares | medium |
| Mar 9, 2026 | Mortimer Ian CEO | Sell | Common Shares | $742.5K | -12K -40.25% | 18,521 0.02% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Fmr LLC | Passive13G/A | — |
| Wellington Management Group LLP | Passive13G | — |
| Janus Henderson Group PLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| XENE | — | 98420N105 |